Akihiro Tamiya - Concepedia

Author

Akihiro Tamiya

NHO Kinki Chuo Chest Medical Center ORCID

Also Known As

A. Tamiya, AKIHIRO TAMIYA, Akihiro Tamiya, Yoshihiko Taniguchi

225

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

NHO Kinki Chuo Chest Medical Center Osaka International Cancer Institute Osaka Prefectural Medical Center National Hospital Organization Toneyama National Hospital

About

Akihiro Tamiya is an author at NHO Kinki Chuo Chest Medical Center specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	836
2	Health Sciences	4	4	94
3	Public Health	1	1	21
4	Epidemiology	1	1	21
5	Geriatrics	1	1	10

Akihiro Tamiya

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR Masaru Watanabe, Tomoya Kawaguchi, Shun‐ichi Isa, Clinical Cancer Research	2015	222
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV Hiroaki Akamatsu, Kiichiro Ninomiya, Hirotsugu Kenmotsu, International Journal of Clinical Oncology	2019	145
Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study Tomoya Kawaguchi, Yasuhiro Koh, Masahiko Ando, Journal of Clinical Oncology	2016	124
Pretreatment advanced lung cancer inflammation index (<scp>ALI</scp>) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer Takayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, Cancer Medicine	2017	121
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations Kenichi Nishie, Tomoya Kawaguchi, Akihiro Tamiya, Journal of Thoracic Oncology Activating Egfr MutationsMedicineReceptor Tyrosine KinaseRetrospective AnalysisPathology	2012	107
Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial Motohiro Tamiya, Akihiro Tamiya, Takako Inoue, PLoS ONE	2018	105
Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study Akihiro Tamiya, Motohiro Tamiya, Takashi Nishihara, Anticancer Research	2017	89
Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma Satoshi Igawa, Haruyasu Murakami, Toshiaki Takahashi, Lung Cancer MedicineUnresectable Thymic CarcinomaPathologyImmune Checkpoint InhibitorCancer Treatment	2009	84
Severe Acute Interstitial Lung Disease After Crizotinib Therapy in a Patient With <i>EML4-ALK</i>–Positive Non–Small-Cell Lung Cancer Akihiro Tamiya, Isamu Okamoto, Masaki Miyazaki, Journal of Clinical Oncology Advanced Lung DiseaseMedicinePulmonary Alveolar ProteinosisPathologyCancer Treatment	2012	70
Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab Yoshihiko Taniguchi, Akihiro Tamiya, Syun-Ichi Isa, Anticancer Research	2017	67

Page 1